Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,665Revenue $M2,463Net Margin (%)15.8Altman Z-Score6.2
Enterprise Value $M7,711EPS $2.3Operating Margin %19.6Piotroski F-Score7
P/E(ttm)21.8Beneish M-Score-2.5Pre-tax Margin (%)20.2Higher ROA y-yY
Price/Book4.410-y EBITDA Growth Rate %31.9Quick Ratio1.4Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %36.7Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow21.4y-y EBITDA Growth Rate %13.9ROA % (ttm)12.7Higher Current Ratio y-yN
Dividend Yield %0.7PEG0.6ROE % (ttm)22.0Less Shares Outstanding y-yY
Payout Ratio %14.0Shares Outstanding M171ROIC % (ttm)20.2Gross Margin Increase y-yN

Gurus Latest Trades with RDY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RDYKen Fisher 2015-12-31 Reduce-0.06%$43.55 - $67.79
($54.62)
$ 44.85-18%Reduce -9.20%4,504,956
RDYKen Fisher 2015-09-30 Reduce-0.03%$55.59 - $67.73
($62.11)
$ 44.85-28%Reduce -4.55%4,961,550
RDYKen Fisher 2015-06-30 Reduce$51.8 - $60.54
($55.23)
$ 44.85-19%Reduce -0.34%5,198,254
RDYKen Fisher 2015-03-31 Add0.12%$47.73 - $57.1
($53.03)
$ 44.85-15%Add 25.58%5,216,225
RDYKen Fisher 2014-06-30 Add0.13%$38.67 - $46.08
($42.03)
$ 44.857%Add 62.43%3,773,114
RDYKen Fisher 2014-03-31 Add0.08%$39.5 - $47.4
($43.29)
$ 44.854%Add 56.30%2,322,863
RDYKen Fisher 2013-06-30 Add0.04%$32.98 - $38.7
($36.5)
$ 44.8523%Add 48.42%1,283,605
RDYKen Fisher 2013-03-31 Add0.02%$32.03 - $36.57
($34.21)
$ 44.8531%Add 31.46%864,830
RDYKen Fisher 2012-09-30 Buy 0.05%$28.94 - $32.58
($30.12)
$ 44.8549%New holding604,555
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RDY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RDY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about RDY:

    News about RDY:

    Articles On GuruFocus.com
    Ken Fisher Sells Shares of PMC Sierra, Alphabet During 4th Quarter Jan 15 2016 
    Emerging Market Stocks To Watch Out For Feb 17 2015 
    Should You Buy Actavis? Mar 18 2014 
    Dr. Reddy’s Laboratories: Should Continue to Gain Market Share in Lucrative Markets May 25 2012 
    5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
    Abbott Laboratories and the “India Cure” for the Ailing Pharmaceutical Industry May 26 2010 

    More From Other Websites
    3:23 am Dr. Reddy's receives FDA approval for Sernivo spray Feb 08 2016
    Promius Pharma™ Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05% Feb 07 2016
    Promius Pharma™ Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05% Feb 07 2016
    Dr. Reddy’s Laboratories Ltd. – Value Analysis (NYSE:RDY) : February 2, 2016 Feb 02 2016
    Dr. Reddy's Laboratories Ltd. receives FDA approval for ZEMBRACE™SymTouch™ (sumatriptan... Feb 02 2016
    Dr. Reddy's Receives FDA Tentative Approval For Zenavod Capsules Feb 01 2016
    SHAREHOLDER ALERT: Scott + Scott, LLP Investigating Dr. Reddy’s Labs (RDY) for Possible Securities... Feb 01 2016
    Dr. Reddy’s Laboratories Receives USFDA Tentative Approval for Zenavod™ (doxycycline) Capsules,... Feb 01 2016
    Dr. Reddy’s Laboratories Receives USFDA Tentative Approval for Zenavod™ (doxycycline) Capsules,... Feb 01 2016
    Dr. Reddy’s Laboratories Receives USFDA Tentative Approval for Zenavod™ (doxycycline) Capsules,... Feb 01 2016
    Dr. Reddy’s Laboratories Ltd. Receives FDA approval for ZEMBRACETMSymTouchTM (sumatriptan... Jan 29 2016
    Dr. Reddy’s Laboratories Ltd. Receives FDA Approval for ZEMBRACE™SymTouch™ (sumatriptan... Jan 29 2016
    Dr. Reddy’s Laboratories Ltd. Receives FDA Approval for ZEMBRACE™SymTouch™ (sumatriptan... Jan 29 2016
    Dr. Reddy's to Release Q3FY16 Results on Feb 9, 2016; Earnings Call Slated for Feb 9, 6:30 PM IST /... Jan 28 2016
    Dr. Reddy's to Release Q3FY16 Results on Feb 9, 2016; Earnings Call Slated for Feb 9, 6:30 PM IST /... Jan 28 2016
    Lifshitz & Miller Law Firm Announces Investigation of BofI Holding, Inc., Capstone Turbine... Jan 18 2016
    Dr. Reddy's (RDY) Relaunches Generic Nexium in the U.S. Dec 31 2015
    Dr. Reddy’s announces the relaunch of Esomeprazole Magnesium Delayed-Release Capsules, USP Dec 30 2015
    Dr. Reddy’s Announces the Relaunch of Esomeprazole Magnesium Delayed-Release Capsules, USP Dec 30 2015
    Dr. Reddy’s Announces the Relaunch of Esomeprazole Magnesium Delayed-Release Capsules, USP Dec 30 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK